Five-Year I AM ALS Impact Report
This community has made incredible strides since I AM ALS’ founding in 2019. The Impact Report chronicles not only the milestones accomplished in 2022, but across almost five years of I AM ALS’ history. Check out the full report for a timeline of accomplishments; an unprecedented return on investment in federal ALS progress and research funding; big appreciation to our supporters and volunteers, and more. Check below for a sneak peek! A downloadable PDF is also available.
None of this impact would have been possible without YOU. Thank you.
Click below to view the full report in all its glory, including embedded videos and clickable links.
Download a PDF of the Impact Report
Want to be part of the next five years of impact? Consider giving to I AM ALS.
We will find cures for ALS. The only question is when. That answer depends on you.
Stay informed on I AM ALS’ progress and what you can do to help us make hope real.
Hummingbird Fund and I AM ALS partner to accelerate therapy approvals and access
We are thrilled to announce a new collaboration between I AM ALS and The Hummingbird Fund, a milestone towards achieving our shared mission of ending ALS through revolutionary policy advocacy.
NurOwn AdComm: What happened? What’s next?
There have been a lot of conversations about NurOwn’s Cellular, Tissue, and Gene Therapies Advisory Committee (AdComm) meeting that occurred on September 27, 2023, the subsequent Biologics License Applications (BLA) removal, and its perceived irregularities.